R Neidenbach, K Niwa, O Oto, E Oechslin… - Cardiovascular …, 2018 - ncbi.nlm.nih.gov
Despite relevant residua and sequels, follow-up care of adults with congenital heart disease (ACHD) is too often not performed by/in specialized and/or certified physicians or centers …
Pulmonary arterial hypertension (PAH) develops in 5–10% of patients with congenital heart disease (CHD)[1], and PAH associated with congenital heart disease (PAH-CHD) accounts …
CS Hjortshøj, T Gilljam, G Dellgren, MO Pentikäinen… - Heart, 2020 - heart.bmj.com
Objective The optimal timing for transplantation is unclear in patients with Eisenmenger syndrome (ES). We investigated post-transplantation survival and transplantation-specific …
SM Kücükoglu, C Kaymaz, D Alehan… - Pulmonary …, 2021 - journals.sagepub.com
Pulmonary hypertension is a group of diseases, including pulmonary arterial hypertension associated with congenital heart disease (APAH-CHD), characterized by progressive …
Objectives. This study is aimed at evaluating the maternal and perinatal characteristics and pregnancy outcomes of ES. Material and Methods. This is a retrospective cohort study of …
Introduction: Eisenmenger syndrome (ES) is the most advanced form of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD). It is characterised by a …
R Neidenbach, S Achenbach, C Andonian… - Herz, 2019 - Springer
Congenital heart diseases (CHD) are the most common types of congenital organ defects. Thanks to medical progress in congenital cardiology and heart surgery, most children with …
F Xie, R Quan, G Zhang, H Tian, Y Chen, Z Yu… - The Journal of Heart and …, 2023 - Elsevier
Background The purpose of this registry was to provide insights into the characteristics, treatments and survival of patients with PAH-CHD in China. Methods Patients diagnosed …
C Karsenty, V Waldmann, B Mulder, S Hascoet… - Clinical Research in …, 2021 - Springer
Despite impressive improvement in long-term survival, adults with congenital heart disease (CHD) remain exposed to a significant cardiovascular morbidity over lifetime …